Trials / Recruiting
RecruitingNCT06314919
A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib
A Multicenter, Prospective, Cohort Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimibe Under the Real-World Condition
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 8,606 (estimated)
- Sponsor
- Boryung Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of fixed-Dose combination of Pitavastatin/Ezetimibe under the real-world condition
Conditions
Timeline
- Start date
- 2024-03-15
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2024-03-18
- Last updated
- 2025-09-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06314919. Inclusion in this directory is not an endorsement.